Search Results 21-30 of 11391 for MOTS-c Analogue

  1. Liver Cirrhosis Network Cohort Study (LCN-C) - Mayo Clinic

    About this study. The purpose of this study is to evaluate improvements in predictive accuracy for risk of decompensation over time for a composite risk ...

  2. Multisystem inflammatory syndrome in children (MIS-C) and COVID-19 - Doctors and departments - Mayo Clinic

    Learn about symptoms of this serious condition linked to coronavirus disease 2019 (COVID-19). Get help fast if your child shows any signs.

  3. APL-101 Study Of Subjects With NSCLC With C-Met EXON 14 Skip Mutations And C-Met Dysregulation Advanced Solid Tumors (SPARTA) - Mayo Clinic

    c-Met dysregulation will be determined by local/archival molecular pre-screening evaluations for eligibility of enrollment. Mayo Clinic will be participating in ...

  4. Clinical trials - Mayo Clinic Children's

    We will assess the presence of C. albicans in the microbial communities of a population of children at-risk for atopic dermatitis compared to healthy controls ...

  5. Publications - Anil Chauhan, M.B.B.S., M.D. - Mayo Clinic

    Gurudu R, Bansal D, Chauhan A, Tirumani SH. Tumor metrics imaging core labs: primer for radiologists. Abdom Radiol (NY). 2026 Sep; 51 (9):4725-4734 Epub ...

  6. Publications - Shannon P. Fortin Ensign, M.D., Ph.D. - Mayo Clinic

    Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL. Tumor necrosis factor-like weak inducer ...

  7. Study Of The Safety, Pharmacokinetics And Efficacy Of EDO-S101, In Patients With Advanced Solid Tumors - Mayo Clinic

    About this study. Tinostamustine (EDO-S101) is a new chemical entity, an AK-DAC (a first-in-class alkylating deacetylase inhibiting molecule) that, ...

  8. Publications - Collin M. Costello, M.D. - Mayo Clinic

    2026 Jul; 95 (1):283-286 Epub 2026 Mar 27. View PubMed; Besch J, Koblinski JE, Motamed M, Yee C, Price H, Costello CM. Pediatric melanoma in Arizona ...

  9. Publications - Konstantinos Leventakos, M.D., Ph.D. - Mayo Clinic

    Williams C, Chesak S, Pachman DR, Rhee L, Dierkhising R, Leventakos K. Feasibility of virtual stress management and resiliency training (smart) for oncology ...

  10. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...